P

PRQR

PRQR

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio100% buys
BearishBullish
PRQR Live QuoteReal-time
$1.05
$0.32(-23.36%)1M
Day Range$1.03 – $1.12
Open$1.11
Previous Close$1.10
Volume805.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$154.05M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.43
Price to Book1.8
Dividend Yield0.65%
Beta (Volatility)0.27
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $1.05 (1%)
Low: $1.03High: $2.48
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$7.56-95.0% upside

Insider Buys

5

$1.34M

Insider Sales

0

$0

Total Volume

$1.34M

10 transactions

Net Activity

+$1.34M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys5 sells

$235.00B total

D
2

De Boer Daniel Anton

CEO

3 buys0 sells

$853K total

F
3

Filius Bart

Dir

2 buys0 sells

$489K total

Trading History
PRQR insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Jul 31, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell500.0K$200000.00$100.00B

Jul 31, 2026

3 months ago

De Boer Daniel Anton

CEO

CEO
Buy200.0K$1.77$354K

Jul 17, 2026

4 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell300.0K$150000.00$45.00B

Jul 17, 2026

4 months ago

Filius Bart

Dir

Director
Buy150.0K$1.72$258K

Jul 9, 2026

4 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell300.0K$150000.00$45.00B

Jul 9, 2026

4 months ago

De Boer Daniel Anton

CEO

CEO
Buy150.0K$1.74$261K

Jul 7, 2026

4 months ago

De Boer Daniel Anton

CEO

CEO
Buy150.0K$1.59$239K

Jul 7, 2026

4 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell150.0K$150000.00$22.50B

Jun 26, 2026

4 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell150.0K$150000.00$22.50B

Jun 26, 2026

4 months ago

Filius Bart

Dir

Director
Buy150.0K$1.54$231K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PRQR Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

PRQR has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PRQR

Over the last 90 days, corporate insiders at PRQR (PRQR) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 5 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.34M.

The net insider activity for PRQR shows a net buying bias of $1.34M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 500.0K shares valued at $100.00B on Jul 31, 2026.

Live Market News & Developments
Aggregated real-time headlines for PRQR (PRQR)
6 updates

Proqr Therapeutics N.v Stock Price Forecast. Should You Buy PRQR?

StockInvest.us3d ago

PRQR Nov 2026 1.000 put (PRQR261120P00001000) stock price, news, quote and history

Yahoo Finance Australia11h ago

ProQR Therapeutics (Nasdaq:PRQR) - Stock Analysis

Simply Wall St3d ago

PRQR - ProQR Therapeutics N.V Stock Price and Quote

Finviz176d ago

ProQR Announces Third Quarter 2026 Operating and Financial Results

The Globe and Mail6d ago

PRQR Forecast — Price Target — Prediction for 2027

TradingView146d ago

FAQs About PRQR Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PRQR.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PRQR is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 5 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for PRQR is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.